Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
Ronald van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Ingemar F. Petersson, Katerina Chatzidionysiou, Johan Bratt
The Lancet, 2012
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.